Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2023 to Q4 2025

Type / Class
Equity / Common Stock, no par value
Symbol
IMDX on Nasdaq
Shares outstanding
32,305,051
Price per share
$7.50
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
16,651,600
Total reported value
$124,888,014
% of total 13F portfolios
0%
Share change
+368,716
Value change
+$2,765,695
Number of holders
34
Price from insider filings
$7.50
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BROADWOOD PARTNERS, L.P. 37% -7% $90,615,668 +$3,913,042 12,082,089 +4.5% Neal C. Bradsher 10 Feb 2026
AWM Investment Company, Inc. 10% +31% $9,685,464 +$5,257,076 2,857,069 +119% AWM Investment Company, Inc. 31 Mar 2025

As of 31 Dec 2025, 34 institutional investors reported holding 16,651,600 shares of Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX). This represents 52% of the company’s total 32,305,051 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX) together control 52% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BROADWOOD CAPITAL INC 35% 11,410,100 0% 5.2% $85,575,750
AWM Investment Company, Inc. 8.7% 2,814,230 -0.29% 2% $21,106,725
PURA VIDA INVESTMENTS, LLC 2.9% 947,134 0% 27% $7,103,505
VANGUARD GROUP INC 1.6% 526,675 +8.2% 0% $3,950,064
GEODE CAPITAL MANAGEMENT, LLC 0.71% 230,971 +16% 0% $1,733,670
BlackRock, Inc. 0.41% 131,361 +49% 0% $985,208
683 Capital Management, LLC 0.24% 77,204 0.05% $579,030
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.22% 72,451 0% $543,383
MILLENNIUM MANAGEMENT LLC 0.19% 61,377 -16% 0% $460,328
NORTHERN TRUST CORP 0.15% 48,858 +49% 0% $366,435
STATE STREET CORP 0.15% 47,754 +14% 0% $358,155
JANE STREET GROUP, LLC 0.13% 42,469 0% $318,517
FNY Investment Advisers, LLC 0.13% 40,584 -24% 0.09% $304,000
MORGAN STANLEY 0.11% 35,913 -42% 0% $269,348
Qube Research & Technologies Ltd 0.09% 28,351 0% $212,633
OMERS ADMINISTRATION Corp 0.08% 26,164 0% $196,230
OSAIC HOLDINGS, INC. 0.07% 24,136 +115% 0% $181,019
GOLDMAN SACHS GROUP INC 0.07% 23,965 0% $179,738
CITADEL ADVISORS LLC 0.05% 15,647 +33% 0% $117,353
RENAISSANCE TECHNOLOGIES LLC 0.04% 13,400 -43% 0% $100,500
Hudson Bay Capital Management LP 0.04% 13,061 0% $97,958
Private Advisor Group, LLC 0.03% 10,416 0% 0% $78,120
EverSource Wealth Advisors, LLC 0.02% 5,000 0% 0% $37,500
UBS Group AG 0.01% 2,941 +8.4% 0% $22,058
ORG Partners LLC 0% 450 0% 0% $3,375

Institutional Holders of Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 16,651,600 $124,888,014 +$2,765,695 $7.50 34
2025 Q3 16,282,884 $54,051,121 +$296,694 $3.32 27
2025 Q2 15,248,594 $46,050,393 +$442,513 $3.02 29
2025 Q1 16,047,858 $49,105,818 +$23,516,169 $3.06 29
2024 Q4 8,368,639 $19,916,902 +$2,876,004 $2.38 25
2024 Q3 7,107,091 $20,255,014 +$3,161,741 $2.85 19
2024 Q2 5,990,280 $17,670,609 +$7,170,223 $2.95 21
2024 Q1 3,559,240 $10,429,392 -$189,496 $2.93 22
2023 Q4 3,624,342 $9,059,295 -$247,783 $2.50 24
2023 Q3 3,718,862 $11,617,455 +$11,614,005 $3.12 26
2023 Q2 15,000 $3,450 +$3,450 $0.23 1